Hui Li Xin Zhou Ding Zhang Guoqiang Wang Xiaochun Cheng Caihong Xu Bin Yao Linrong Pang Jun Chen
10.3389/fmed.2020.00366
Front Med (Lausanne)
2020 Jul 28;7:366.
biomarker immunotherapy nivolumab ovarian cancer pseudo-progression
CC BY
https://pubmed.ncbi.nlm.nih.gov/32850889/
Case Reports
PMC7399050
32850889
Early Onset Immune-Related Adverse Event to Identify Pseudo-Progression in a Patient With Ovarian Cancer Treated With Nivolumab: A Case Report and Review of the Literature
2020